` PPBT (Purple Biotech Ltd) vs Tel Aviv 355 Comparison - Alpha Spread

P
PPBT
vs
T
Tel Aviv 355

Over the past 12 months, PPBT has underperformed Tel Aviv 355, delivering a return of -71% compared to the Tel Aviv 355's +53% growth.

Stocks Performance
PPBT vs Tel Aviv 355

Loading
PPBT
Tel Aviv 355
Add Stock
www.alphaspread.com

Performance Gap
PPBT vs Tel Aviv 355

Loading
PPBT
Tel Aviv 355
Difference
www.alphaspread.com

Performance By Year
PPBT vs Tel Aviv 355

Loading
PPBT
Tel Aviv 355
Add Stock

Competitors Performance
Purple Biotech Ltd vs Peers

Tel Aviv 355
PPBT
LLY
JNJ
NOVO B
ROG
Add Stock

Purple Biotech Ltd
Glance View

Market Cap
22.7m ILS
Industry
Pharmaceuticals

Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

PPBT Intrinsic Value
4.56 ILS
Undervaluation 3%
Intrinsic Value
Price
P
Back to Top